Arena Runs on NDA (ARNA)

Posted in pre-market 
December 22nd, 2009

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) filed its new drug application with the FDA for lorcaserin, its key promising weight loss drug.   Shares closed at $3.74 yesterday and are up 4% at $3.89 on 101,500 pre-market shares as of 8:40 AM EST.


Comments are closed